Prof Anthony Gordon MBE, FMedSci is the Head of Division of Anaesthetics, Pain Medicine and Intensive Care at Imperial, an NIHR Senior Investigator and Director of the NIHR Health Technology Assessment Programme. His research focuses on developing precision medicine in sepsis.

He leads a multidisciplinary group investigating the use of -omic techniques and artificial intelligence (AI) to improve outcomes in sepsis. He has led multiple clinical trials that have shaped international sepsis guidelines. He leads the Bayesian adaptive platform trial REMAP-CAP, for COVID-19 and influenza in the UK, that has improved treatments for and saved hundreds of thousands of lives from severe COVID-19 around the world.